Autocrine Stimulatory Mechanism by Transforming Growth Factor β in Human Hepatocellular Carcinoma
2000
The serum concentration of transforming growth factor β (TGF-β) is
elevated as tumors progress in hepatocellular carcinoma (HCC) patients.
In this study, we examined whether modulation of tumor-derived TGF-β
signal transduction contributes to malignant progression. We
investigated the production of TGF-β 1 , the biological
effects of TGF-β and neutralizing antibody on HCC cells, activation
of Smad 2, Smad 3, and Smad 4, induction of antagonistic Smads (Smad 6
and Smad 7), and promoter activities of two target genes,
plasminogen activator inhibitor type 1
( PAI-1 ) and
p15 INK4B . In human cell lines
HCC-M and HCC-T, TGF-β accelerates their proliferation. Smad 2 was
activated constitutively by an autocrine mechanism, because in the
absence of exogenous TGF-β, a high level of Smad 2 phosphorylation,
induction of PAI-1 transcripts, and nuclear localization of
Smad 2 were observed. This constitutive activation of Smad 2 was, at
least in part, attributable to the lack of induction of antagonistic
Smads by TGF-β. However, Smads activated by tumor-derived TGF-β
constantly suppressed p15 INK4B expression. In
addition, 3 of 10 human HCC tissues showed nuclear localization of Smad
2 and low mRNA levels of p15 INK4B and
antagonistic Smads but a high level of PAI-1 . Our
observations suggest that this constant suppression of the
p15 INK4B gene could be involved in the
malignant progression of HCC.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
34
References
85
Citations
NaN
KQI